Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease - Preliminary report

Neurologia i Neurochirurgia Polska

Volumn 42, Issue 4, 2008, Pages 312-315

  Paradowski, Bogusław ^a   Celczyńska, Dorota ^a   Dodosz, Tadeusz ^a   Noga, Leszek ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Alzheimer's disease; Interleukin 6; Polymorphism

Indexed keywords

DNA; INTERLEUKIN 6;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA EXTRACTION; ELECTROPHORESIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RISK FACTOR;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 56649117352     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Barton B.E. The biological effects of interleukin 6. Med Res Rev 1996; 16: 87-109.
2. Papassotiropoulos A., Hock C., Nitsch R.M. Genetic of interleukin-6: implication for Alzheimer's disease. Neurobiol Aging 2001; 22: 863-871.
3. Licastro F., Grimaldi L.M., Bonafe N., et al. Interleukin-6 gene allele affect the risk of Alzheimer's disease and levels of the cytokines in blood and brain. Neurobiol Aging 2003; 24: 921-926.
4. Faltraco F., Bürger K., Zill P, et al. Interleukin-6-174G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatr Soc 2003; 51: 578-579.
5. Mrak R.E., Sheng J.G., Griffin W.S.T. Glial cytokines in Alzheimer's disease: review and pathogenic implication. Hum Path 1995; 26: 816-823.
6. Pola R., Flex A., Gaetani E., et al. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected]. Neuroreport 2002; 13: 1645-1647.
7. Shibata N., Ohnuma T, Takahashi T, et al. Effect of IL-6 polymorphism on risk of Alzheimer's disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 2002; 114: 436-439.
8. McKhann G., Drachman D., Folestein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
9. Bohjak T.J., DeKosky S.T., Ganguli M., et al. Genetic polymorphism in the cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 2000; 288: 21-24.
10. Bagli M., Papassotiropoulos A., Knapp M., et al. Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in German population. Neurosci Lett 2000; 283: 109-112.
11. Ravaglia G., Paola F., Maioli F., et al. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factor for AD; a prospective study. Exp Gerontol 2006; 41: 85-92.
12. van Oijen M., Arp P.P., de Jong F.J., et al. Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci Lett 2006; 402: 113-117.
13. Hang Y., Hayes A., Pritchard A., et al. Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease. Neurosci Lett 2004; 362: 99-102.
14. Depboylu C., Lohmüller F, Gocke P., et al. An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 17: 170-173.
15. Ravaglia G., Paola F., Maioli F, et al. Interleukin 1-beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study. Exp Gerontol 2006; 41: 85-92.